CompaniesIncline Therapeutics

Incline Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

155

By Phase

PHASE3: 1PHASE1: 1PHASE4: 1

By Status

COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details

Recent Trials

NCT02395653Collaborator
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
PHASE3Completed
71 participants
Started: Jun 29, 2015 · Completed: Sep 12, 2016
NCT01750060Lead Sponsor
Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).
PHASE1Completed
54 participants
Started: Dec 31, 2012 · Completed: Mar 31, 2013
NCT01202149Collaborator
Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis
PHASE4Completed
30 participants
Started: Mar 31, 2010 · Completed: Nov 30, 2010
Funding History (3)
D
Sep 27, 2011
Filing
D
Jun 30, 2010
Filing
D
Jan 20, 2010
Filing
Related Companies
The Medicines Company
acquired